IMPACT OF BUSULFAN, ETOPOSIDE AND HIGH-DOSE ARA-C (BEA) CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN AML

被引：0

作者：

Sanz, Jaime ^{[1
,2
]}

Labopin, Myriam ^{[3
]}

Daskalakis, Michael ^{[4
]}

Broers, A. E. C. ^{[5
]}

Van Gorkom, Gwendolyn ^{[6
]}

Meijer, Ellen ^{[7
]}

Gedde-Dah, Tobias ^{[8
]}

Montoro, Juan ^{[1
,2
]}

Arcese, William ^{[9
]}

Antonio Perez-Simon, Jose ^{[10
]}

Schaap, N. ^{[11
]}

Maertens, Johan ^{[12
]}

Vrhovac, Radovan ^{[13
]}

Lanza, Francesco ^{[14
]}

Gorin, Norbert Claude ^{[15
]}

Mohty, Mohamad ^{[15
]}

Ciceri, Fabio ^{[16
]}

机构：

[1] Hosp Univ & Politecn La Fe, Valencia, Spain

[2] Inst Carlos III, CIBERONC, Madrid, Spain

[3] Hosp St Antoine, EBMT Paris Off, Paris, France

[4] Univ Hosp Bern, Paediat Hematol Oncol, Bern, Switzerland

[5] Erasmus MC, Univ Med Ctr Rotterdam, Inst Canc, Rotterdam, Netherlands

[6] Univ Hosp Maastricht, Maastricht, Netherlands

[7] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[8] Oslo Univ Hosp, Sect Stem Cell Transplantat, Clin Canc Med, Rikshosp, Oslo, Norway

[9] Tor Vergata Univ Rome, Stem Cell Transplant Unit, Policlin Univ Vergata, Rome, Italy

[10] Hosp Univ Virgen Rocio, Serv Hematol & Hemoterapia, Serv Andaluz Salud, Seville, Spain

[11] Nijmegen Med Ctr, Nijmegen, Netherlands

[12] Univ Hosp Gasthuisberg, Leuven, Belgium

[13] Univ Hosp Ctr Rebro, Zagreb, Croatia

[14] Osped Civile, Unita Operat Ematol, Ravenna, Italy

[15] Sorbonne Univ, Hop St Antoine, INSERM UMRs 938, Paris, France

[16] Ospedale San Raffaele srl, Haematol & BMT, Milan, Italy

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

O054

引用

页码：57 / 57

页数：1

共 50 条

[1] THE COMPARISON OF BEEAM (BENDAMUSTINE, ETOPOSIDE, ARA-C AND MELPHALAN) AND BEAM (BCNU, ETOPOSIDE, ARA-C AND MELPHALAN) CONDITIONING REGIMENS IN LYMPHOMA PATIENTS TREATED WITH AUTOLOGOUS STEM CELL TRANSPLANTATION
Mikhailova, N.
Kondakova, E.
Maramy-Zonouzi, N.
Bondarenko, S.
Podoltseva, E.
Medvedeva, N.
Popova, M.
Ryabchikova, V.
Afanasiev, B.
BONE MARROW TRANSPLANTATION, 2014, 49 : S448 - S449
[2] SEQUENTIAL HIGH-DOSE ARA-C AND ASPARAGINASE IN UNTREATED AML EFFICACY OF A SINGLE DAILY DOSE OF HIGH-DOSE ARA-C
POWELL, BL
CRUZ, JM
LYERLY, ES
RUSSELL, GB
WOOD, JH
STUART, RK
CHORLEY, HM
CAPIZZI, RL
BLOOD, 1993, 82 (10) : A129 - A129
[3] BUSULFAN PLUS CYCLOPHOSPHAMIDE AND ETOPOSIDE VERSUS HIGH-DOSE MELPHALAN AS CONDITIONING IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA
Park, Seonyang
Lee, Youngjoon
Lim, Sungnam
BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 484 - 484
[4] Busulfan plus cyclophosphamide and etoposide versus high-dose melphalan as conditioning in autologous stem cell transplantation for newly diagnosed multiple myeloma
Lim, Sungnam
Park, Seon Yang
Lee, Yongjun
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S153 - S153
[5] Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
Cogle, CR
Moreb, JS
Leather, HL
Finiewicz, KJ
Khan, SA
Reddy, VS
Wingard, JR
AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (03) : 169 - 175
[6] The impact of high-dose ara-C and rituximab in up-front autologous stem cell transplantation for mantle cell lymphoma: a retrospective analysis of 98 patients
Rieger, M
Hensel, M
Benner, A
Seyfarth, B
Schoch, R
Sitter, S
Martin, S
Haas, R
Kneba, M
Schmitz, N
Ho, AD
Dreger, P
BONE MARROW TRANSPLANTATION, 2006, 37 : S234 - S234
[7] Busulfan,cyclophosphamide and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma
张春阳
China Medical Abstracts(Internal Medicine), 2013, 30 (02) : 116 - 117
[8] Comparison of Melphalan Combined with Treosulfan or Busulfan as High-Dose Chemotherapy before Autologous Stem Cell Transplantation in AML
Gurevich, Ekaterina
Hayoz, Michael
Aebi, Yolanda
Largiader, Carlo R.
Mansouri Taleghani, Behrouz
Bacher, Ulrike
Pabst, Thomas
CANCERS, 2022, 14 (04)
[9] Electroencephalogram abnormality and high-dose busulfan in conditioning regimens for stem cell transplantation
R Kobayashi
N Watanabe
A Iguchi
Y Cho
M Yoshida
H Arioka
H Naito
T Shikano
Y Ishikawa
Bone Marrow Transplantation, 1998, 21 : 217 - 220
[10] High-dose infusional ifosfamide, etoposide plus methylprednisolone followed by dexamethasone, high-dose ara-C and cisplatinum and autologous stem cell transplantation for refractory or relapsed aggressive non-Hodgkin's lymphoma
Salar, A
Martino, R
Perea, G
Ribera, JM
López-Guillermo, A
Guardia, R
Escoda, L
Altés, A
Sierra, J
Montserrat, E
HAEMATOLOGICA, 2002, 87 (10) : 1028 - 1035

← 1 2 3 4 5 →